The Fidelity MSCI Health Care Index ETF provides broad sector exposure at a lower cost than the State Street SPDR S&P Biotech ETF. The SPDR ETF experienced a much deeper 54% maximum drawdown over the past five years compared to the Fidelity fund.
State Street Corporation (STT) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the firm maintains a stable equity base of $27.7 billion, the extreme volatility in operating cash flow and the unpredictable nature of its 17.88 P/E multiple warrant a cautious approach.
State Street Corporation (STT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
State Street Corporation (STT) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 17, 2026 | $2.84vs $2.64+7.6% | $3.8Bvs $3.7B+3.6% |
| Q1 2026 | Jan 16, 2026 | $2.97vs $2.84+4.6% | $3.7Bvs $3.6B+1.8% |
| Q4 2025 | Oct 17, 2025 | $2.78vs $2.64+5.3% | $5.7Bvs $3.5B+66.1% |
| Q3 2025 | Jul 15, 2025 | $2.53vs $2.35+7.7% | $5.8Bvs $3.4B+72.8% |
Recent stock market news and headlines for State Street Corporation (STT)
The Fidelity MSCI Health Care Index ETF provides broad sector exposure at a lower cost than the State Street SPDR S&P Biotech ETF. The SPDR ETF experienced a much deeper 54% maximum drawdown over the past five years compared to the Fidelity fund.
The State Street SPDR S&P Bank ETF offers a broader portfolio and slightly lower expense ratio than the iShares U.S. Regional Banks ETF. While the iShares U.S. Regional Banks ETF has higher 1-year total returns, it has experienced significantly deeper drawdowns over the past five years.
The current environment favors custody banks. State Street stock is up 32% this year.
In this article series, I summarize dividend announcements of the past week. Thirteen companies in my database (including 7 banks) announced dividend increases. JPMorgan Chase stands out with a 10% dividend hike, an A+ safety grade, and a new $50B buyback, and trades only 3.35% above fair value. Matson is the week's high-quality non-bank, boasting a 7.34 quality score, 9.4 safety score, and a conservative 10% payout ratio.
HOOD, BEN and STT lead finance-sector gains in Q2 as retail trading, stronger AUM trends and supportive rates power investor optimism.
Key metrics vs top competitors for State Street Corporation (STT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $169.67 | $46.96B | 18.05 | 2.98% | 13.01% | 11.08% | 1.82% | |
| $141.91 | $100.01B | 19.15 | 2.25% | 14.66% | 13.32% | — | |
| $181.39 | $33.57B | 20.75 | -9.93% | 12.83% | 14.45% | — | |
| $34.36 | $17.85B | 37.76 | 3.45% | 8.99% | 5.64% | — | |
| $27.40 | $12.17B | -17.13 | 5.11% | -3.69% | -1.74% | — | |
| $1042.98 | $321.24B | 20.32 | -1.38% | 16.31% | 14.31% | — |
State Street Corporation (STT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
State Street Corporation (STT) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 26, 2026·SEC
Apr 24, 2026·SEC
Apr 17, 2026·SEC
Feb 19, 2026·SEC
Apr 29, 2026·SEC
Get notified when STT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
State Street Corporation (STT) stock FAQ — growth, dividends, profitability & financials explained
State Street Corporation (STT) grew revenue by 3.0% over the past year. Growth has been modest.
Yes, State Street Corporation (STT) is profitable, generating $3.06B in net income for fiscal year 2025 (13.0% net margin).
Yes, State Street Corporation (STT) pays a dividend with a yield of 1.82%. This makes it attractive for income-focused investors.
State Street Corporation (STT) has a return on equity (ROE) of 11.1%. This is reasonable for most industries.
State Street Corporation (STT) has a net interest margin (NIM) of 0.8%. NIM has been under pressure due to interest rate environment.
State Street Corporation (STT) has an efficiency ratio of 44.9%. This is excellent, indicating strong cost control.